Zhijun Geng

机构：Sun Yat-sen University, Key Laboratory of Guangdong Province, Guangzhou Chemistry (China), Sun Yat-sen University Cancer Center, First Affiliated Hospital of Bengbu Medical College

发表论文 42 篇 · 总被引 542 次 · h-index 12

代表论文

• Camrelizumab (a PD-1 inhibitor) plus apatinib (an VEGFR-2 inhibitor) and hepatic artery infusion chemotherapy for hepatocellular carcinoma in Barcelona Clinic Liver Cancer stage C (TRIPLET): a phase II study (2023 · Signal Transduction and Targeted Therapy · 被引 128)
• Atractylenolide III ameliorates spinal cord injury in rats by modulating microglial/macrophage polarization (2022 · CNS Neuroscience & Therapeutics · 被引 85)
• Deep learning nomogram based on Gd-EOB-DTPA MRI for predicting early recurrence in hepatocellular carcinoma after hepatectomy (2023 · European Radiology · 被引 51)
• Nomograms for Predicting Hepatocellular Carcinoma Recurrence and Overall Postoperative Patient Survival (2022 · Frontiers in Oncology · 被引 30)
• Deep convolutional neural network for preoperative prediction of microvascular invasion and clinical outcomes in patients with HCCs (2021 · European Radiology · 被引 27)
• Discriminating rectal cancer grades using restriction spectrum imaging (2022 · Abdominal Radiology · 被引 19)